Search Results

Active, currently enrolling    Who can join   

OptimICE-pCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy

Keywords: Obstetrics and Gynecology;Oncology (Adult);
Study Type: Clinical Trial   |  Region: Colorado

---

Enrollment complete    Who can join   

Alternate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant Treatment (ALTERNATE) in Postmenopausal Women: A Phase III Study

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment on hold    Who can join   

The Association of Breast Density Changes, Plasma Hormone Changes, and Breast Cancer Recurrence: A Companion Study to NCIC CTG MA.27

Keywords: Oncology (Adult);Obstetrics and Gynecology; stage I breast cancer, stage II…
Study Type: Other Observational Study with Direct Patient Contact   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment on hold    Who can join   

A Phase III Trial of Accelerated Whole Breast Irradiation With Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast Cancer

Keywords: Oncology (Adult);Obstetrics and Gynecology;stage IA breast cancer, stage IB…
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment on hold    Who can join   

Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer (e3)

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: Clinical Trial   |  Region: California - Northern

---

Active, currently enrolling    Who can join   

Cluster Randomized Controlled Trial of Patient and Provider Decision Support to Increase Chemoprevention Informed Choice Among Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Making Informed Choices on Incorporating Chemoprevention Into Care (MiChoice)

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: Prospective Cohort Study with Direct Patient Contact   |  Region: California - Northern

---

Enrollment on hold    Who can join   

A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer

Keywords: Oncology (Adult);Obstetrics and Gynecology;Urology;
Study Type: Clinical Trial   |  Region: California - Northern

---

Enrollment complete    Who can join   

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With = 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy

Keywords: Oncology (Adult);Obstetrics and Gynecology;
Study Type: Clinical Trial   |  Region: Colorado

---